The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 564K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robert, C.
Right arrow Articles by Kupper, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robert, C.
Right arrow Articles by Kupper, T. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/2/627/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 4, February 15, 1999 627-636


Articles

Interaction of Dendritic Cells with Skin Endothelium: A New Perspective on Immunosurveillance

Caroline Robert*, Robert C. Fuhlbrigge*, J. David Kieffer*, Seyoum Ayehunie{ddagger}, Richard O. Hynes§, Guiying Cheng||, Stephan Grabbe*, Ulrich H. von Andrian||, and Thomas S. Kupper*

From the * Harvard Skin Disease Research Center, Division of Dermatology, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, Massachusetts 02115; {ddagger} MatTek Corporation, Ashland, Massachusetts 01721; the § Center for Cancer Research, Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 01239; and the || Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115

The goal of this study was to determine the mechanisms by which dendritic cells (DCs) in blood could interact with endothelium, a prerequisite to extravasation into tissues. Our results indicate that DCs express both HECA-452–reactive and nonreactive isoforms of P-selectin glycoprotein ligand 1 (PSGL-1) and can tether and roll efficiently on E- and P-selectin under flow conditions in vitro. Freshly isolated blood DCs were further observed to roll continuously along noninflamed murine dermal endothelium in vivo. This interaction is strictly dependent on endothelial selectins, as shown by experiments with blocking antibodies and with E- and P-selectin–deficient mice. We hypothesize that DCs in blood are constitutively poised at the interface of blood and skin, ready to extravasate upon induction of inflammation, and we showed that cutaneous inflammation results in a rapid recruitment of DCs from the blood to tissues. We propose that this is an important and previously unappreciated element of immunosurveillance.

Key Words: inflammation • immunosurveillance • selectins • rolling • extravasation


Address correspondence to Thomas S. Kupper, Harvard Skin Disease Research Center, Division of Dermatology, Department of Medicine, Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115. Phone: 617-525-5550; Fax: 617-525-5571; E-mail: tskupper{at}rics.bwh.harvard.edu

Abbreviations used: CLA, cutaneous lymphocyte-associated antigen; DC, dendritic cell; PSGL-1, P-selectin glycoprotein ligand 1; VCAM-1, vascular cell adhesion molecule 1; VLA-4, very late antigen 4.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS